Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNK | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | NUP37 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | MRPL22 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | ZNF232 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | INA | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | CERK | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | AC092835.2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | RP11-201K10.3 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | SCAI | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | N4BP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |